103 related articles for article (PubMed ID: 20674579)
1. Cardiovascular determinants and prognostic significance of CC Chemokine Ligand-18 (CCL18/PARC) in patients with stable coronary artery disease.
De Sutter J; Struyf S; Van de Veire NR; Philippé J; De Buyzere M; Van Damme J
J Mol Cell Cardiol; 2010 Nov; 49(5):894-6. PubMed ID: 20674579
[TBL] [Abstract][Full Text] [Related]
2. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
3. CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders.
Chang CY; Lee YH; Leu SJ; Wang CY; Wei CP; Hung KS; Pai MH; Tsai MD; Wu CH
Neuroscience; 2010 Feb; 165(4):1233-43. PubMed ID: 19958819
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma chemokine CCL18/PARC in beta-thalassemia.
Dimitriou E; Verhoek M; Altun S; Karabatsos F; Moraitou M; Youssef J; Boot R; Sarafidou J; Karagiorga M; Aerts H; Michelakakis H
Blood Cells Mol Dis; 2005; 35(3):328-31. PubMed ID: 16137900
[TBL] [Abstract][Full Text] [Related]
5. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
[TBL] [Abstract][Full Text] [Related]
6. Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis.
Kodera M; Hasegawa M; Komura K; Yanaba K; Takehara K; Sato S
Arthritis Rheum; 2005 Sep; 52(9):2889-96. PubMed ID: 16142750
[TBL] [Abstract][Full Text] [Related]
7. Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.
de Jager SC; Bongaerts BW; Weber M; Kraaijeveld AO; Rousch M; Dimmeler S; van Dieijen-Visser MP; Cleutjens KB; Nelemans PJ; van Berkel TJ; Biessen EA
PLoS One; 2012; 7(9):e45804. PubMed ID: 23029252
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
9. CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events?
Hedman A; Larsson PT; Alam M; Wallen NH; Nordlander R; Samad BA
Int J Cardiol; 2007 Aug; 120(1):108-14. PubMed ID: 17141340
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis.
Schutyser E; Struyf S; Wuyts A; Put W; Geboes K; Grillet B; Opdenakker G; Van Damme J
Eur J Immunol; 2001 Dec; 31(12):3755-62. PubMed ID: 11745396
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients.
Park CO; Lee HJ; Lee JH; Wu WH; Chang NS; Hua L; Lee MG; Lee KH
Exp Dermatol; 2008 Jan; 17(1):24-9. PubMed ID: 17979978
[TBL] [Abstract][Full Text] [Related]
13. CCL18 is expressed in patients with bullous pemphigoid and parallels disease course.
Günther C; Carballido-Perrig N; Kopp T; Carballido JM; Pfeiffer C
Br J Dermatol; 2009 Apr; 160(4):747-55. PubMed ID: 19120345
[TBL] [Abstract][Full Text] [Related]
14. Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions.
van der Voort R; Kramer M; Lindhout E; Torensma R; Eleveld D; van Lieshout AW; Looman M; Ruers T; Radstake TR; Figdor CG; Adema GJ
J Leukoc Biol; 2005 May; 77(5):739-47. PubMed ID: 15713699
[TBL] [Abstract][Full Text] [Related]
15. A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes.
Hieshima K; Imai T; Baba M; Shoudai K; Ishizuka K; Nakagawa T; Tsuruta J; Takeya M; Sakaki Y; Takatsuki K; Miura R; Opdenakker G; Van Damme J; Yoshie O; Nomiyama H
J Immunol; 1997 Aug; 159(3):1140-9. PubMed ID: 9233607
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
[TBL] [Abstract][Full Text] [Related]
17. Expression of chemokine (C-C motif) ligand 18 in human macrophages and atherosclerotic plaques.
Hägg DA; Olson FJ; Kjelldahl J; Jernås M; Thelle DS; Carlsson LM; Fagerberg B; Svensson PA
Atherosclerosis; 2009 Jun; 204(2):e15-20. PubMed ID: 19036375
[TBL] [Abstract][Full Text] [Related]
18. Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study.
De Castro-Orós I; Irún P; Cebolla JJ; Rodriguez-Sureda V; Mallén M; Pueyo MJ; Mozas P; Dominguez C; Pocoví M;
J Transl Med; 2017 Feb; 15(1):43. PubMed ID: 28222799
[TBL] [Abstract][Full Text] [Related]
19. PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.
Struyf S; Schutyser E; Gouwy M; Gijsbers K; Proost P; Benoit Y; Opdenakker G; Van Damme J; Laureys G
Am J Pathol; 2003 Nov; 163(5):2065-75. PubMed ID: 14578205
[TBL] [Abstract][Full Text] [Related]
20. CCL2, CCL18 and sIL-4R in renal, meningeal and pulmonary TB; a 2 year study of patients and contacts.
Mendez A; Hernandez-Pando R; Contreras S; Aguilar D; Rook GA
Tuberculosis (Edinb); 2011 Mar; 91(2):140-5. PubMed ID: 21251883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
